Gosta Labs

Gosta Labs Oy, founded in 2023 in Espoo, Finland, specializes in healthcare AI technology. Gosta Labs has executed one deal as of November 27, 2025.Gosta Labs specializes in advanced AI solutions designed specifically for the healthcare sector, with its flagship product being the Gosta AI Operating System. This system integrates features akin to a personal assistant with the intelligence of an AI operating system, automating administrative tasks such as note generation and patient data structuring, ultimately enabling healthcare professionals to focus more on patient interactions. The Gosta AI Operating System has been implemented across tens of thousands of clinical appointments, demonstrating its utility in real-world clinical settings. The primary end users of Gosta Labs' products include healthcare professionals and providers in public and private healthcare settings across various regions, including Europe and potentially extending to global markets.Gosta Labs generates revenue through partnerships and subscriptions, providing its AI solutions to healthcare providers and institutions. The company's primary offering, the Gosta AI Operating System, is available on a subscription basis, allowing clients to integrate the AI systems into their existing workflows seamlessly. Transaction structures typically involve direct partnerships with healthcare organizations, where Gosta Labs collaborates closely to implement its solutions in clinical settings. Revenue streams are bolstered by the adoption of Gosta Aide, a personal assistant tool that enhances productivity for healthcare professionals. The company aims to enter new geographic markets with a focus on enhancing its presence in Europe and potentially other global regions.

1. Seed

   Nov 27, 2025

   Amount

   $8.7M

   Investors

   Locked